School of Medicine
Showing 1-10 of 99 Results
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Heather Radford, PA-C
Affiliate, Medicine - Med/Blood and Marrow Transplantation
BioHeather Radford, PA-C is the Lead Advanced Practice Provider for the Blood and Marrow Transplant Program. She completed her MHS and PA studies at Duke University in 2007. She then started her career in inpatient pulmonary and critical care at Johns Hopkins from 2007-2011. She transitioned her practice to the Johns Hopkins inpatient hematologic malignancies and Bone Marrow Transplant program from 2011-2013. She moved back west and landed in beautiful Palo Alto, California. She joined the Stanford BMT program in September 2013 and shortly thereafter was promoted to Lead APP. Her area of clinical practice is bone marrow transplant and cancer cellular therapies. She practices on the inpatient service as well l as the infusion treatment area in addition to her leadership role.
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Rishi Raj
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Rishi Raj is an Clinical Professor of Medicine at Stanford University and directs the Interstitial Lung Disease program at Stanford. He specializes in the diagnosis and treatment of interstitial lung diseases and has practiced pulmonary and critical care medicine for more than 15 years. Dr. Raj's primary clinical interest and primary focus of clinical research is interstitial lung diseases including idiopathic pulmonary fibrosis, other idiopathic interstitial lung diseases, drug induced interstitial lung diseases, interstitial lung disease associated with connective tissue diseases including scleroderma, rheumatoid arthritis, dermatomyositis etc., sarcoidosis, hypersensitivity pneumonitis and other miscellaneous interstitial lung diseases. Dr. Raj is the principal investigator and co-investigator on multiple clinical trials evaluating new therapies for treating idiopathic pulmonary fibrosis and pulmonary fibrosis/interstitial lung disease from other etiologies.
